Literature DB >> 16708701

Cognitive impairment in patients with brain tumors: assessment and intervention in the clinic setting.

Sherry W Fox1, Sandra A Mitchell, Margaret Booth-Jones.   

Abstract

Cognitive impairment is the most common neurologic problem associated with brain tumors and is present in many people with brain tumors from the time of diagnosis. Treatment of primary brain tumors with surgery, radiation, chemotherapy, and adjunctive medications such as corticosteroids results in further adverse effects on cognitive function. To plan the best care for patients with brain tumors, healthcare providers must initiate systematic and accurate assessment of cognitive functioning at the first clinic visit and extend assessment throughout the course of illness. This article outlines the range of cognitive dysfunction that may be seen in patients with primary brain tumors and offers information for clinicians seeking to develop their skills and implement a systematic approach to cognitive screening. The use of cognitive screening to guide timely intervention, such as referral to a neuropsychologist and the provision of anticipatory guidance to people with brain tumors and their families, is discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16708701     DOI: 10.1188/06.CJON.169-176

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  8 in total

1.  Changes in caregiver perceptions over time in response to providing care for a loved one with a primary malignant brain tumor.

Authors:  Allison Hricik; Heidi Donovan; Sarah E Bradley; Barbara A Given; Catherine M Bender; Alyssa Newberry; Rebekah Hamilton; Charles W Given; Paula Sherwood
Journal:  Oncol Nurs Forum       Date:  2011-03       Impact factor: 2.172

2.  Neuropsychological Predictors of Decision-Making Capacity in Terminally Ill Patients with Advanced Cancer.

Authors:  Elissa Kolva; Barry Rosenfeld; Rebecca M Saracino
Journal:  Arch Clin Neuropsychol       Date:  2019-01-24       Impact factor: 2.813

3.  Feasibility study of the Montreal Cognitive Assessment (MoCA) in patients with brain metastases.

Authors:  Robert Anton Olson; Taruna Chhanabhai; Michael McKenzie
Journal:  Support Care Cancer       Date:  2008-03-12       Impact factor: 3.603

4.  Functional Improvement After 4-Week Rehabilitation Therapy and Effects of Attention Deficit in Brain Tumor Patients: Comparison With Subacute Stroke Patients.

Authors:  Eun Young Han; Min Ho Chun; Bo Ryun Kim; Ha Jeong Kim
Journal:  Ann Rehabil Med       Date:  2015-08-25

5.  Reliability of self-report versus the capacity to consent to treatment instrument to make medical decisions in brain metastasis and other metastatic cancers.

Authors:  Mackenzie E Fowler; Dario A Marotta; Richard E Kennedy; Adam Gerstenecker; Meredith Gammon; Kristen Triebel
Journal:  Brain Behav       Date:  2021-10-02       Impact factor: 2.708

6.  Development of an item bank for computerized adaptive testing of self-reported cognitive difficulty in cancer patients.

Authors:  Linda Dirven; Martin Jb Taphoorn; Mogens Groenvold; Esther Jj Habets; Neil K Aaronson; Thierry Conroy; Jaap C Reijneveld; Teresa Young; Morten Aa Petersen
Journal:  Neurooncol Pract       Date:  2017-01-19

7.  Regionally distinct responses of microglia and glial progenitor cells to whole brain irradiation in adult and aging rats.

Authors:  Kun Hua; Matthew K Schindler; Joseph A McQuail; M Elizabeth Forbes; David R Riddle
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

8.  Profiling Cognitive Deficits in Intra-Axial and Extra-Axial Tumors Using Addenbrooke's Cognitive Examination as a Screening Tool: An Indian Experience.

Authors:  Sandhya Cherkil; Dilip Panikar; Deepak Kuttikkattu Soman
Journal:  Asian J Neurosurg       Date:  2017 Oct-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.